Agilent Technologies Inc.

128.01
0.09 (0.07%)
At close: Mar 03, 2025, 12:52 PM

Company Description

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide.

It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics.

The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services.

The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce.

Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Agilent Technologies Inc.
Agilent Technologies Inc. logo
Country United States
IPO Date Nov 18, 1999
Industry Medical - Diagnostics & Research
Sector Healthcare
Employees 18,000
CEO Padraig McDonnell

Contact Details

Address:
5301 Stevens Creek Boulevard
Santa Clara, California
United States
Website https://www.agilent.com

Stock Details

Ticker Symbol A
Exchange NYSE
Fiscal Year November - October
Reporting Currency USD
CIK Code 0001090872
CUSIP Number 00846U101
ISIN Number US00846U1016
Employer ID 77-0518772
SIC Code 3826

Key Executives

Name Position
Padraig McDonnell Chief Executive Officer, President & Director
Bret M. DiMarco Senior Vice President, Chief Legal Officer, & Secretary
Robert W. McMahon C.M.A. Senior Vice President & Chief Financial Officer
Chris Swenson Vice President & Interim Chief Human Resources Officer
Dr. Simon May SVice President & President of LDG
Frederick Schwarz SVice President, Chief Strategy & Corporate Development Officer
Henrik Ancher-Jensen Senior Vice President and President of Order Fulfillment & Supply Chain
Parmeet Ahuja Vice President of Investor Relations
Rodney Gonsalves Principal Accounting Officer, Vice President & Corporate Controller
Yvonne Mackie MD of UK & Ireland Operations and Vice President of Human Resources - Europe

Latest SEC Filings

Date Type Title
Feb 26, 2025 8-K Current Report
Feb 21, 2025 DEFA14A Filing
Feb 13, 2025 SCHEDULE 13G/A [Amend] Filing
Jan 31, 2025 DEFA14A Filing
Jan 31, 2025 ARS Filing
Jan 31, 2025 DEF 14A Filing
Jan 30, 2025 4 Filing
Jan 23, 2025 4 Filing
Jan 14, 2025 PRE 14A Filing
Dec 20, 2024 10-K Annual Report